FDA weighs approval of Alzheimer's drug, but benefits iffy – Georgia Health News

0
149

The Meals and Drug Administration’s resolution subsequent week whether or not to approve the primary therapy for Alzheimer’s illness highlights a deep division over the drug’s advantages in addition to criticism concerning the integrity of the FDA approval course of.

Adblock take a look at (Why?)

LEAVE A REPLY

Please enter your comment!
Please enter your name here